Quotient Sciences Acquires Arcinova

Read the press release here

-Stephen Brown PhD FRPharmS, Pharmaceutical and Biotech Consultant

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The World Health Organization classified the COVID-19 outbreak as a pandemic in early March 2020 as the disease reached most areas of the world, infecting hundreds of thousands of people and killing thousands.

Click here to be emailed a copy of our whitepaper